Ceapro Inc. Receives Approval from Health Canada to Commence Phase 1/2a Human Clinical Trial Assessing Avenanthramide Tablets
– Ceapro is pioneering approach with a natural product as a potential anti-inflammatory – Clinical study…
News
Novo Nordisk A/S:
Novo Nordisk A/S – Share repurchase programme Bagsværd, Denmark, 22 December 2022 – On 4…
Outlook Therapeutics® Announces Validation of Marketing Authorization Application by the European Medicines Agency for ONS-5010 as a Treatment for Wet AMD
Decision for potential approval expected from European Commission in early 2024 Submission follows the U.S….
Cognition Therapeutics Announces New “Conversations” Podcast Episode on Key Insights from Recent Clinical Trials in Alzheimer’s Disease
– Features Alzheimer’s Experts: Christopher van Dyck, M.D. and Anton Porsteinsson, M.D. – PURCHASE, N.Y.,…
BioAtla to Participate in the 41st Annual J.P. Morgan Healthcare Conference
SAN DIEGO, Dec. 22, 2022 (GLOBE NEWSWIRE) — BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage…
Tulsa ER & Hospital Adopts Trailblazing MeMed BV® Test
Tulsa ER & Hospital Adopts Trailblazing MeMed BV® Test Tulsa ER & Hospital is…
INmune Bio, Inc., Virginia Commonwealth University, and Barrow Neurological Institute Receive Department of Defense Funding to Study the Role of Traumatic Brain Injury in the Development of Alzheimer’s Disease
XPro1595 decreases development of amyloid beta and tau following TBI in murine model of Alzheimer’s…
Appeals Court Affirms Validity of Collegium’s Belbuca® Patents
Ruling bars ANDA filer Alvogen from entering market until 2032 patent expiry STOUGHTON, Mass., Dec….
Aquestive Therapeutics Announces Completion of FDA End-of-Phase 2 Meeting For AQST-109 (epinephrine sublingual film)
FDA continues to indicate that the Company can conduct a comparability study rather than efficacy…
Acasti Pharma Announces Preliminary Topline Results Met All Primary Outcome Measures in the Single Dose Pharmacokinetic Study for GTX-101, the Company’s Drug Candidate for the Treatment of Postherpetic Neuralgia (PHN)
LAVAL, Québec, Dec. 22, 2022 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (“Acasti” or the “Company”)…
Otonomy Announces Change in Stock Exchange Listing
SAN DIEGO, Dec. 22, 2022 (GLOBE NEWSWIRE) — Otonomy, Inc. (Nasdaq: OTIC) today announced that it…
TOWER ONE WIRELESS ANNOUNCES FOURTEEN TOWERS COMPLETED – ADDITIONAL NON-CANCELLABLE RENT OF $ 1,750,000
TOWER ONE CONSTRUCTION UPDATE FOR THE MONTH OF NOVEMBER 2022 VANCOUVER, BC, CANADA , Dec….
Start the Year with more savings. Switch to Verizon for just $25 per line. Guaranteed for 3 years.
Welcome to Verizon. For a limited time, get the savings you want on the network…
Jitterbit Sees Record Growth in E-Commerce Customers and Partners
E-Commerce Heavyweights Partner with Jitterbit, Bringing Crucial Connections, Speed and Agility to Retailers Worldwide ALAMEDA,…
Founder Of Black Swan Media, Bruno Souza, Offers His Expert Advice On How Businesses Can Increase Their Traffic, Conversions, And Sales
Las Vegas, Nevada, Dec. 22, 2022 (GLOBE NEWSWIRE) — Bruno Souza is a successful entrepreneur,…
Intermap Announces $1 Million Insurance Subscription
Subscription renewals grow in dollars and contract duration in the fourth quarter Intermap expects full…
MEXC Launches the Broker Program
Toronto, Ontario–(Newsfile Corp. – December 22, 2022) – On December 20th, MEXC, the cryptocurrency trading…
Online Yoga School Pioneer Joins Forbes Business Council
San Antonio, Texas–(Newsfile Corp. – December 22, 2022) – Online Yoga School pioneer Steph Ball-Mitchell…
RETRANSMISSION: HIVE Blockchain Provides Results from Shareholder Meeting and Announces Opportunistic Acquisitions of Energy Efficient Bitmain S19j Pro Miners to Take HIVE to Target 3 Exahash in the New Year
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus…
Henriksen Selects DCS Cloud-Based IoT Solutions to Manage and Monitor High-Value Assets
San Diego, California–(Newsfile Corp. – December 22, 2022) – Direct Communication Solutions, Inc. (OTCQX: DCSX)…